Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart

Antioxidants and Redox Signaling

Volumn 8, Issue 9-10, 2006, Pages 1635-1649

  Ago, Tetsuro ^a   Yeh, Ijen ^a   Yamamoto, Mitsutaka ^a   Schinke Braun, Martina ^b   Brown, Jeffrey A ^b   Tian, Bin ^a   Sadoshima, Junichi ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; MITOCHONDRIAL PROTEIN; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; THIOREDOXIN; THIOREDOXIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR A; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CITRIC ACID CYCLE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; ENZYME REGULATION; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HEART; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART PROTECTION; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSGENIC MOUSE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CITRATE (SI)-SYNTHASE; CITRIC ACID CYCLE; CYTOCHROMES C; DNA-BINDING PROTEINS; DOWN-REGULATION; ELECTRON TRANSPORT COMPLEX IV; GENE EXPRESSION PROFILING; HIGH MOBILITY GROUP PROTEINS; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MYOCARDIUM; NUCLEAR RESPIRATORY FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE PHOSPHORYLATION; THIOREDOXIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; UP-REGULATION;

MUS MUSCULUS;

EID: 33750405658     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.1635     Document Type: Article

References (38)

1. Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, and Sadoshima J. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res 95: 971-980, 2004.
2. Benjamini Y and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57: 289-300, 1995.
3. Bland JM and Altman DG. Multiple significance tests: the Bonferroni method. BMJ 310: 170, 1995.
4. Bossy-Wetzel E and Green DR. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 274: 17484-17490, 1999.
5. Burke-Gaffney A, Callister ME, and Nakamura H. Thioredoxin: friend or foe in human disease? Trends Pharmacol Sci 26: 398-404, 2005.
6. Chiueh CC, Andoh T, and Chock PB. Induction of thioredoxin and mitochondrial survival proteins mediates preconditioning-induced cardioprotection and neuroprotection. Ann N Y Acad Sci 1042: 403-418, 2005.
7. Crooks GE, Hon G, Chandonia JM, and Brenner SE. WebLogo: a sequence logo generator. Genome Res 14: 1188-1190, 2004.
8. Eisen MB, Spellman PT, Brown PO, and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868, 1998.
9. Ghezzi P. Oxidoreduction of protein thiols in redox regulation. Biochem Soc Trans 33: 1378-1381, 2005.
10. Hansen JM, Watson WH, and Jones DP. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol Sci 82: 308-317, 2004.
11. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spiegelman B, and Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413: 179-183, 2001.
12. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966, 1989.
13. Huo L and Scarpulla RC. Mitochondrial DNA instability and peri-implantation lethality associated with targeted disruption of nuclear respiratory factor 1 in mice. Mol Cell Biol 21: 644-654,2001.
14. Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, Utsumi H, Hamasaki N, and Takeshita A. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 88: 529-535, 2001.
15. Kanehisa M and Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 28: 27-30, 2000.
16. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, and Wingender E. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 31: 3576-3579, 2003.
17. Kelly DP and Scarpulla RC. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 18: 357-368, 2004.
18. Kent WJ. BLAT: the BLAST-like alignment tool. Genome Res 12: 656-664, 2002.
19. Kishimoto C, Shioji K, Nakamura H, Nakayama Y, Yodoi J, and Sasayama S. Serum thioredoxin (TRX) levels in patients with heart failure. Jpn Circ J 65: 491-494, 2001.
20. Larkin JE, Frank BC, Gaspard RM, Duka I, Gavras H, and Quackenbush J. Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiol Genomics 18: 152-166, 2004.
21. Meuillet EJ, Mahadevan D, Berggren M, Coon A, and Powis G. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys 429: 123-133, 2004.
22. Nakamura H, Nakamura K, and Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997.
23. Nonn L, Williams RR, Erickson RP, and Powis G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 23: 916-922, 2003.
24. Piantadosi CA and Suliman HB. Mitochondrial transcription factor A induction by redox activation of nuclear respiratory factor 1. J Biol Chem 281: 324-333, 2006.
25. Pruitt KD and Maglott DR. RefSeq and LocusLink: NCBI gene-centered resources. Nucleic Acids Res 29: 137-140, 2001.
26. Shioji K, Kishimoto C, Nakamura H, Masutani H, Yuan Z, Oka S, and Yodoi J. Overexpression of thioredoxin-1 in transgenic mice attenuates Adriamycin-induced cardiotoxicity. Circulation 106: 1403-1409, 2002.
27. Shioji K, Nakamura H, Masutani H, and Yodoi J. Redox regulation by thioredoxin in cardiovascular diseases. Antioxid Redox Signal 5: 795-802, 2003.
28. Solaini G and Harris DA. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J 390: 377-394, 2005.
29. Tanaka T, Nishiyama Y, Okada K, Hirota K, Matsui M, Yodoi J, Hiai H, and Toyokuni S. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney, independence of tubular necrosis and sulfhydryl depletion. Lab Invest 77: 145-155, 1997.
30. Tao L, Gao E, Bryan NS, Qu Y, Liu HR, Hu A, Christopher TA, Lopez BL, Yodoi J, Koch WJ, Feelisch M, and Ma XL. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]. Proc Natl Acad Sci U S A 101: 11471-11476, 2004.
31. Tian B, Hu J, Zhang H, and Lutz CS. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res 33: 201-212, 2005.
32. Turoczi T, Chang VW, Engelman RM, Maulik N, Ho YS, and Das DK. Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol 35: 695-704, 2003.
33. Tusher VG, Tibshirani R, and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121, 2001.
34. Wingender E, Dietze P, Karas H, and Knuppel R. TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res 24: 238-241, 1996.
35. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V Troy A, Cinti S, Lowell B, Scarpulla RC, and Spiegelman BM. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115-124, 1999.
36. Yamamoto M, Yang G, Hong C, Liu J, Holle E, Yu X, Wagner T, Vatner SF, and Sadoshima J. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 112: 1395-1406, 2003.
37. Yamawaki H, Haendeler J, and Berk BC. Thioredoxin: a key regulator of cardiovascular homeostasis. Circ Res 93: 1029-1033, 2003.
38. Yoshioka J, Schulze PC, Cupesi M, Sylvan JD, MacGillivray C, Gannon J, Huang H, and Lee RT. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Circulation 109: 2581-2586, 2004.